CE: DETAIL

Low-Molecular-Weight Heparins in Renal Impairment and Obesity

To develop practical recommendations for the use of low-molecular-weight heparins (LMWHs) as prophylaxis and treatment of venous thromboembolism and acute coronary syndromes in patients with impaired renal function or obesity.

Expires on: Jun 01, 2012

City: , AL

Cost: $ 10.00

Contact Hours: 1.5

Link to Program: http://www.pharmace.com/abstracts/2009/lmwh.html

Specialty / Area of Interest: Renal

Category: Pharmacy

Provider of Program: The Annals of Pharmacotherapy